search
Back to results

Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System

Primary Purpose

Intestinal Disease, Inflammatory Bowel Diseases, Crohn Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
SV-3 Capsule Endoscopy
Sponsored by
Capso Vision, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Intestinal Disease focused on measuring Intestinal Disease, Inflammatory Bowel Diseases, Crohn Disease, Ulcer, Celiac Disease, Angioectasia, Polyp

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Male or Female
  • Willing and able to provide written informed consent
  • Completion of pre-study questionnaire
  • Approval of study principal investigator

Exclusion Criteria:

  • Subjects with abdominal pain of unknown origin
  • Difficulty Swallowing
  • Known or suspected gastrointestinal disease
  • Diarrhea or constipation
  • Anemia of unknown origin
  • Rectal or other gastrointestinal bleeding
  • Pregnancy

Sites / Locations

  • CapsoVision, Inc.

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

SV-3 Capsule Endoscopy

Arm Description

CapsoCam SV-3 Capsule Endoscopy system will perform in a manner consistent with the performance of the CapsoCam SV-3 capsule endoscopy systems.

Outcomes

Primary Outcome Measures

Ability to capture images
Images are captured throughout an entire small bowel exam, with complete small bowel exam defined as the ability of the capsule to reach the cecum while still recording images.
Ability to download images
Images are correctly downloaded using the CapsoAccess Capsule Data Access System (CDAAS3).
Diagnostic Quality of Images
Small bowel images of diagnostic quality are able to be reviewed using the CapsoView CVV Software and determined to be effective for diagnostic purposes by the study investigator.

Secondary Outcome Measures

Full Information

First Posted
February 7, 2020
Last Updated
September 28, 2020
Sponsor
Capso Vision, Inc.
Collaborators
Generic Devices Consulting, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT04573959
Brief Title
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
Official Title
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
October 1, 2015 (Actual)
Primary Completion Date
June 11, 2020 (Actual)
Study Completion Date
June 11, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Capso Vision, Inc.
Collaborators
Generic Devices Consulting, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To validate an updated version of CapsoCam® SV-3 Endoscopy System brand name CapsoCam Plus™) with respect to the reproducibility of the system to capture and download small bowel images in a manner consistent with the predicate CapsoCam® SV-2 and SV-3 capsule endoscopy systems.
Detailed Description
The purpose of the study is validate the an updated version of the CapsoCam® SV-3 Endoscopy System brand name CapsoCam Plus™) with respect to the reproducibility of the system to capture and download small bowel images in a manner consistent with the predicate CapsoCam® SV-2 and SV-3 capsule endoscopy systems. The system to be validated consists of an updated version of the CapsoCam® SV-3 video capsule endoscope, the CapsoView® CVV Software, the CapsoAccess ® Capsule Data Access System (CDAS3) and the CapsoRetrieve® Capsule Retrieval Kit for the collection of the excreted CapsoCam capsule. The captured CapsoCam® SV-3 capsule images of the small bowel will be downloaded via the CapsoAccess® Capsule Data Access System (CDAS3) to a computer and proprietary CapsoView® CVV Software is used to review capsule images. The CapsoView® software displays the video and employs a variety of image-enhancement, video playback, and image analysis features to facilitate physician review of the captured images. The software allows the physician to efficiently annotate individual frames from the video and compile a procedure report, which aids in diagnosis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intestinal Disease, Inflammatory Bowel Diseases, Crohn Disease, Ulcer, Celiac Disease
Keywords
Intestinal Disease, Inflammatory Bowel Diseases, Crohn Disease, Ulcer, Celiac Disease, Angioectasia, Polyp

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
84 (Actual)

8. Arms, Groups, and Interventions

Arm Title
SV-3 Capsule Endoscopy
Arm Type
Experimental
Arm Description
CapsoCam SV-3 Capsule Endoscopy system will perform in a manner consistent with the performance of the CapsoCam SV-3 capsule endoscopy systems.
Intervention Type
Device
Intervention Name(s)
SV-3 Capsule Endoscopy
Other Intervention Name(s)
Capsule Endoscopy System
Intervention Description
The purpose of this study is to validate an updated version of the CapsoCam SV-3 Endoscopy System with respect to the reproducibility of the system to capture and download small bowel images in a manner consistent with the predicate CapsoCam SV-3 capsule endoscopy.
Primary Outcome Measure Information:
Title
Ability to capture images
Description
Images are captured throughout an entire small bowel exam, with complete small bowel exam defined as the ability of the capsule to reach the cecum while still recording images.
Time Frame
2 weeks
Title
Ability to download images
Description
Images are correctly downloaded using the CapsoAccess Capsule Data Access System (CDAAS3).
Time Frame
2 weeks
Title
Diagnostic Quality of Images
Description
Small bowel images of diagnostic quality are able to be reviewed using the CapsoView CVV Software and determined to be effective for diagnostic purposes by the study investigator.
Time Frame
2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Male or Female Willing and able to provide written informed consent Completion of pre-study questionnaire Approval of study principal investigator Exclusion Criteria: Subjects with abdominal pain of unknown origin Difficulty Swallowing Known or suspected gastrointestinal disease Diarrhea or constipation Anemia of unknown origin Rectal or other gastrointestinal bleeding Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David Shields, MD
Organizational Affiliation
CapsoVision Research Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
CapsoVision, Inc.
City
Saratoga
State/Province
California
ZIP/Postal Code
95070
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System

We'll reach out to this number within 24 hrs